Association between IL28B polymorphisms and first-phase viral load decrease in chronic hepatitis C virus-infected patients treated with peginterferon alfa-2b/ribavirin. [electronic resource]
- International journal of antimicrobial agents Dec 2011
- 538-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1872-7913
10.1016/j.ijantimicag.2011.08.010 doi
Antiviral Agents--therapeutic use Hepacivirus--drug effects Hepatitis C, Chronic--drug therapy Humans Interferon alpha-2 Interferon-alpha--therapeutic use Interferons Interleukins--genetics Polyethylene Glycols--therapeutic use Polymorphism, Single Nucleotide--genetics Recombinant Proteins--therapeutic use Ribavirin--therapeutic use Treatment Outcome Viral Load--drug effects